GE HealthCare Announces 510(k) Submission for CleaRecon DL Technology Designed to Improve Image Quality in the Interventional Suite With AI-Based Reconstruction
December 04, 2024
December 04, 2024
CHICAGO, Illinois, Dec. 4 -- G.E. HealthCare issued the following news release on Dec. 3, 2024:
* * *
- CleaRecon DL/* is designed to improve cone-beam computed tomography (CBCT) image quality by removing streaks and help clinicians improve their confidence in image interpretation when analyzing CBCT data
* * *
GE HealthCare (Nasdaq: GEHC) announced today the 510(k) submission to the U.S. Food and Drug Administration for CleaRecon DL, deep lear . . .
* * *
- CleaRecon DL/* is designed to improve cone-beam computed tomography (CBCT) image quality by removing streaks and help clinicians improve their confidence in image interpretation when analyzing CBCT data
* * *
GE HealthCare (Nasdaq: GEHC) announced today the 510(k) submission to the U.S. Food and Drug Administration for CleaRecon DL, deep lear . . .